Harpreet K Mandhair (Harpreet Mandhair)

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Venues

Leukemia

Chemical science

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Harpreet K Mandhair, Ramin Radpour, Mira Westerhuis, Yara Banz, Magali Humbert, Miroslav Arambasic, Jörn Dengjel, Andrew Davies, Mario P Tschan, Urban Novak
Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach. Leukemia 38 (2) (2024)
Harpreet K Mandhair, Ramin Radpour, Mira Westerhuis, Yara Banz, Magali Humbert, Miroslav Arambasic, Jörn Dengjel, Andrew Davies, Mario P Tschan, Urban Novak
Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach. Leukemia 38 (2) (2024)
Harpreet K Mandhair, Ramin Radpour, Mira Westerhuis, Yara Banz, Magali Humbert, Miroslav Arambasic, Jörn Dengjel, Andrew Davies, Mario P Tschan, Urban Novak
Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach. Leukemia (2024)
Harpreet K Mandhair, Ramin Radpour, Mira Westerhuis, Yara Banz, Magali Humbert, Miroslav Arambasic, Jörn Dengjel, Andrew Davies, Mario P Tschan, Urban Novak
Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach. Leukemia 38 (2) (2024)
Harpreet K Mandhair, Ramin Radpour, Mira Westerhuis, Yara Banz, Magali Humbert, Miroslav Arambasic, Jörn Dengjel, Andrew Davies, Mario P Tschan, Urban Novak
Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach. Leukemia 38 (2) (2024)
Harpreet K Mandhair, Ramin Radpour, Mira Westerhuis, Yara Banz, Magali Humbert, Miroslav Arambasic, Jörn Dengjel, Andrew Davies, Mario P Tschan, Urban Novak
Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach. Leukemia 38 (2) (2024)
Harpreet K Mandhair, Ramin Radpour, Mira Westerhuis, Yara Banz, Magali Humbert, Miroslav Arambasic, Jörn Dengjel, Andrew Davies, Mario P Tschan, Urban Novak
Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach. Leukemia 38 (2) (2024)
Katja Seipel, Yvo Brügger, Harpreet K Mandhair, Vera Ulrike Bacher, Thomas Pabst
Rationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2- and FLT3-Mutated Acute Myeloid Leukemia. International journal of molecular sciences 23 (20) (2022)
Thais Gazzi, Benjamin Brennecke, Kenneth Atz, Claudia Korn, David Sykes, Gabriel Forn-Cuni, Patrick Pfaff, Roman C Sarott, Matthias V Westphal, Yelena Mostinski, Leonard Mach, Malgorzata Wasinska-Kalwa, Marie Weise, Bradley L Hoare, Tamara Miljuš, Maira Mexi, Nicolas Roth, Eline J Koers, Wolfgang Guba, André Alker, Arne C Rufer, Eric A Kusznir, Sylwia Huber, Catarina Raposo, Elisabeth A Zirwes, Anja Osterwald, Anto Pavlovic, Svenja Moes, Jennifer Beck, Matthias Nettekoven, Irene Benito-Cuesta, Teresa Grande, Faye Drawnel, Gabriella Widmer, Daniela Holzer, Tom van der Wel, Harpreet K Mandhair, Michael Honer, Jürgen Fingerle, Jörg Scheffel, Johannes Broichhagen, Klaus Gawrisch, Julián Romero, Cecilia J Hillard, Zoltan V Varga, Mario van der Stelt, Pal Pacher, Jürg Gertsch, Christoph Ullmer, Peter J McCormick, Sergio Oddi, Herman P Spaink, Mauro Maccarrone, Dmitry B Veprintsev, Erick M Carreira, Uwe Grether, Marc Nazare
Detection of cannabinoid receptor type 2 in native cells and zebrafish with a highly potent, cell-permeable fluorescent probe. Chemical science 13 (19) (2022)

Harpreet K Mandhair.css-eqlu8i{font-size:small;padding-left:4px;} (Harpreet Mandhair)

Publication Activity (10 Years)

Top Topics

Top Venues

Harpreet K Mandhair (Harpreet Mandhair)